T1 and T2 bladder cancer

Selecting optimal therapy

M. S. Soloway

Research output: Contribution to journalArticle

2 Citations (Scopus)
Original languageEnglish
Pages (from-to)16-17
Number of pages2
JournalEuropean Urology
Volume33
Issue numberSUPPL. 4
StatePublished - Jun 2 1998
Externally publishedYes

Fingerprint

Local Neoplasm Recurrences
BCG Vaccine
Combined Modality Therapy
Transitional Cell Carcinoma
Cystectomy
Adjuvant Chemotherapy
Urinary Bladder Neoplasms
Antineoplastic Agents
Therapeutics

ASJC Scopus subject areas

  • Urology

Cite this

Soloway, M. S. (1998). T1 and T2 bladder cancer: Selecting optimal therapy. European Urology, 33(SUPPL. 4), 16-17.

T1 and T2 bladder cancer : Selecting optimal therapy. / Soloway, M. S.

In: European Urology, Vol. 33, No. SUPPL. 4, 02.06.1998, p. 16-17.

Research output: Contribution to journalArticle

Soloway, MS 1998, 'T1 and T2 bladder cancer: Selecting optimal therapy', European Urology, vol. 33, no. SUPPL. 4, pp. 16-17.
Soloway MS. T1 and T2 bladder cancer: Selecting optimal therapy. European Urology. 1998 Jun 2;33(SUPPL. 4):16-17.
Soloway, M. S. / T1 and T2 bladder cancer : Selecting optimal therapy. In: European Urology. 1998 ; Vol. 33, No. SUPPL. 4. pp. 16-17.
@article{b1a04286aaad42cea69ad5805f3241d6,
title = "T1 and T2 bladder cancer: Selecting optimal therapy",
author = "Soloway, {M. S.}",
year = "1998",
month = "6",
day = "2",
language = "English",
volume = "33",
pages = "16--17",
journal = "European Urology",
issn = "0302-2838",
publisher = "Elsevier",
number = "SUPPL. 4",

}

TY - JOUR

T1 - T1 and T2 bladder cancer

T2 - Selecting optimal therapy

AU - Soloway, M. S.

PY - 1998/6/2

Y1 - 1998/6/2

UR - http://www.scopus.com/inward/record.url?scp=0031972315&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031972315&partnerID=8YFLogxK

M3 - Article

VL - 33

SP - 16

EP - 17

JO - European Urology

JF - European Urology

SN - 0302-2838

IS - SUPPL. 4

ER -